1 Item 1A. Risk Factors 21 Item 1B. Unresolved Staff Comments 57 Item 1C. Cybersecurity 57 Item 2. Properties 59 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuers Purchases of Equity Securities 60 Item 6. [Reserved] 62 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 63 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 75 Item 8...
Q2 FY2026 — expected 2026-08-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076536 | EDGAR | 77K words |
| 2025-03-03 | 2024-12-31 | 0000950170-25-030394 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021253 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005079 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001564590-22-008112 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001564590-21-012607 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0001564590-20-009016 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001564590-19-006772 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001564590-18-004911 | EDGAR | — |
| 2017-03-14 | 2016-12-31 | 0001193125-17-081863 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-03 | 2025-09-30 | 0001193125-25-262521 | EDGAR | 22K words |
| 2025-08-04 | 2025-06-30 | 0000950170-25-101985 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063518 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0000950170-24-121439 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000950170-24-089241 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055053 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000950170-23-058165 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037943 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018806 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021848 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0000950170-22-015523 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001564590-22-018873 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001193125-26-076522 | EDGAR | 4K words |
| 2026-01-12 | 0001193125-26-010486 | EDGAR | — |
| 2025-12-19 | 0001193125-25-326961 | EDGAR | — |
| 2025-11-03 | 0001193125-25-262509 | EDGAR | — |
| 2025-10-24 | 0001193125-25-250052 | EDGAR | — |
| 2025-08-04 | 0000950170-25-101974 | EDGAR | — |
| 2025-06-26 | 0000950170-25-090205 | EDGAR | — |
| 2025-05-16 | 0000950170-25-073555 | EDGAR | — |
| 2025-05-05 | 0000950170-25-063514 | EDGAR | — |
| 2025-03-03 | 0000950170-25-030392 | EDGAR | — |
193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001395937 |
| Ticker | SNDX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.syndax.com |
| Listed | 2016-03-03 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report